Following months of negotiations and various offers, Germany-based Bayer has finally sealed the deal with Monsanto, purchasing the seed giant for $66 billion. The merger is reported to be the largest all-cash deal on record.
The purchase means a lot of things, and none of them good for consumers. For one, it strengthens the monopolization of the world’s food supply. It also means more genetically modified organisms (GMOs) and chemicals to be doused on them.
Now, some are predicting the merge could also mean the takeover of the marijuana industry. Monsanto has an intimate business relationship with Scotts Miracle-Gro, “a convicted corporate criminal– and Scott’s Miracle-Gro is trying to take over the marijuana industry,” according to Big Buds Mag.
Is Monsanto going after the pot industry?
Scott’s Miracle-Gro has looked to capitalize on the expanding pot industry in states where the plant has been legalized or decriminalized. The company’s CEO, Jim Hagadorn, stated his intentions to spend up to $500 million to completely buy out the marijuana industry.
A Scott’s Miracle-Gro front group has already purchased General Hydroponics, Botanicare and Gavita.
“Major hydroponics nutrients, lighting, soil, and other grow equipment manufacturers report they’ve also been offered takeover bids by Scotts Miracle-Gro or its ‘Hawthorne’ front company.
“Maximum Yield Magazine, which bans marijuana hydroponics nutrients company Advanced Nutrients from its indoor gardening expo events, welcomed a Monsanto affiliate into its Boston gardening expo several years ago.”
Bayer is of course playing a role in this planned monopolization, as well. The German chemical company does business with GW Pharmaceuticals, a company based in the United Kingdom that grows cannabis and produces medicines from its compounds.